Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effects of Different Coffee Amounts on Energy Intake, Appetite, Glucose Metabolism and Inflammatory Markers

19. desember 2011 oppdatert av: M. Yannakoulia, Harokopio University

The Effect of Different Amounts of Coffee on Dietary Intake, Appetite-related Feeling, Appetite Hormones, Glucose Metabolism and Inflammatory Markers of Normal Weight and Overweight/Obese Individuals

The purpose of the study is to investigate whether different doses of caffeinated coffee consumption has acute effects on subjective appetite feelings, energy intake and biochemical markers related to appetite, inflammation and glucose metabolism compared to water consumption in normal weight and overweight/obese participants.

Studieoversikt

Status

Fullført

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Faktiske)

33

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Athens, Hellas, 17671
        • Metabolic Unit of the Department of Nutrition and Dietetics, Harokopio University

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 45 år (Voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • apparently healthy
  • habitual coffee drinkers (>= 1cup of coffee/day)

Exclusion Criteria:

  • smokers
  • restrained eaters (as this was evaluated using the Dutch Eating Behaviour Questionnaire)
  • those who reported slimming or any other dietary regime
  • athletes
  • participants with a known diagnosis of either hypertension, diabetes, impaired glucose tolerance or a fasting blood glucose concentration above 125 mg/dl
  • subjects on medication for hypertension or on medication known to alter glucose metabolism
  • subjects who were on medication that may have an impact on appetite and sensory functioning or who reported a metabolic or
  • endocrine disease,
  • gastrointestinal disorders,
  • a history of medical or surgical events that may have affected the study outcomes

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Crossover-oppdrag
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: coffee3
Comparison of different amounts of coffee
Eksperimentell: coffee6
Comparison of different amounts of coffee
Placebo komparator: water
Comparison of different amounts of coffee

Hva måler studien?

Primære resultatmål

Resultatmål
Tidsramme
energy intake ad libitum
Tidsramme: 180 min after breakfast/drink consumption
180 min after breakfast/drink consumption
total energy intake
Tidsramme: One day
One day
appetite feelings
Tidsramme: fasting (-15 min)
fasting (-15 min)
appetite feelings
Tidsramme: immediately after breakfast/drink consumption (0 min)
immediately after breakfast/drink consumption (0 min)
appetite feelings
Tidsramme: 15 min after breakfast/drink consumption
15 min after breakfast/drink consumption
appetite feelings
Tidsramme: 30 min after breakfast/drink consumption
30 min after breakfast/drink consumption
appetite feelings
Tidsramme: 60 min after breakfast/drink consumption
60 min after breakfast/drink consumption
appetite feelings
Tidsramme: 90 min after breakfast/drink consumption
90 min after breakfast/drink consumption
appetite feelings
Tidsramme: 120 min after breakfast/drink consumption
120 min after breakfast/drink consumption
appetite feelings
Tidsramme: 150 min after breakfast/drink consumption
150 min after breakfast/drink consumption
appetite feelings
Tidsramme: 180 min after breakfast/drink consumption
180 min after breakfast/drink consumption
appetite hormones
Tidsramme: fasting (-15 min)
fasting (-15 min)
appetite hormones
Tidsramme: immediately after breakfast/drink consumption (0 min)
immediately after breakfast/drink consumption (0 min)
appetite hormones
Tidsramme: 15 min after breakfast/drink consumption
15 min after breakfast/drink consumption
appetite hormones
Tidsramme: 30 min after breakfast/drink consumption
30 min after breakfast/drink consumption
appetite hormones
Tidsramme: 60 min after breakfast/drink consumption
60 min after breakfast/drink consumption
appetite hormones
Tidsramme: 90 min after breakfast/drink consumption
90 min after breakfast/drink consumption
appetite hormones
Tidsramme: 120 min after breakfast/drink consumption
120 min after breakfast/drink consumption
appetite hormones
Tidsramme: 150 min after breakfast/drink consumption
150 min after breakfast/drink consumption
appetite hormones
Tidsramme: 180 min after breakfast/drink consumption
180 min after breakfast/drink consumption
markers of inflammation
Tidsramme: fasting (-15 min)
fasting (-15 min)
markers of inflammation
Tidsramme: immediately after breakfast/drink consumption (0 min)
immediately after breakfast/drink consumption (0 min)
markers of inflammation
Tidsramme: 15 min after breakfast/drink consumption
15 min after breakfast/drink consumption
markers of inflammation
Tidsramme: 30 min after breakfast/drink consumption
30 min after breakfast/drink consumption
markers of inflammation
Tidsramme: 60 min after breakfast/drink consumption
60 min after breakfast/drink consumption
markers of inflammation
Tidsramme: 90 min after breakfast/drink consumption
90 min after breakfast/drink consumption
markers of inflammation
Tidsramme: 120 min after breakfast/drink consumption
120 min after breakfast/drink consumption
markers of inflammation
Tidsramme: 150 min after breakfast/drink consumption
150 min after breakfast/drink consumption
markers of inflammation
Tidsramme: 180 min after breakfast/drink consumption
180 min after breakfast/drink consumption
markers of glucose metabolism
Tidsramme: fasting (-15 min)
fasting (-15 min)
markers of glucose metabolism
Tidsramme: immediately after breakfast/drink consumption (0 min)
immediately after breakfast/drink consumption (0 min)
markers of glucose metabolism
Tidsramme: 15 min after breakfast/drink consumption
15 min after breakfast/drink consumption
markers of glucose metabolism
Tidsramme: 30 min after breakfast/drink consumption
30 min after breakfast/drink consumption
markers of glucose metabolism
Tidsramme: 60 min after breakfast/drink consumption
60 min after breakfast/drink consumption
markers of glucose metabolism
Tidsramme: 90 min after breakfast/drink consumption
90 min after breakfast/drink consumption
markers of glucose metabolism
Tidsramme: 120 min after breakfast/drink consumption
120 min after breakfast/drink consumption
markers of glucose metabolism
Tidsramme: 150 min after breakfast/drink consumption
150 min after breakfast/drink consumption
markers of glucose metabolism
Tidsramme: 180 min after breakfast/drink consumption
180 min after breakfast/drink consumption

Sekundære resultatmål

Resultatmål
Tidsramme
% carbohydrates ad libitum
Tidsramme: 180 min after breakfast/drink consumption
180 min after breakfast/drink consumption
% carbohydrates total day
Tidsramme: One day
One day
% protein ad libitum
Tidsramme: 180 min after breakfast/drink consumption
180 min after breakfast/drink consumption
% protein total day
Tidsramme: One day
One day
% fat
Tidsramme: 180 min after breakfast/drink consumption
180 min after breakfast/drink consumption
% fat total day
Tidsramme: One day
One day

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Etterforskere

  • Hovedetterforsker: Mary Yannakoulia, PhD, Harokopio University

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. januar 2011

Primær fullføring (Faktiske)

1. juni 2011

Studiet fullført (Faktiske)

1. juni 2011

Datoer for studieregistrering

Først innsendt

16. desember 2011

Først innsendt som oppfylte QC-kriteriene

19. desember 2011

Først lagt ut (Anslag)

20. desember 2011

Oppdateringer av studieposter

Sist oppdatering lagt ut (Anslag)

20. desember 2011

Siste oppdatering sendt inn som oppfylte QC-kriteriene

19. desember 2011

Sist bekreftet

1. desember 2011

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • CofSt3

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .